These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 28947128

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Locomotion disturbances in Huntington's disease].
    Delval A, Krystkowiak P.
    Rev Neurol (Paris); 2010 Feb; 166(2):213-20. PubMed ID: 19604530
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.
    Fisher SP, Schwartz MD, Wurts-Black S, Thomas AM, Chen TM, Miller MA, Palmerston JB, Kilduff TS, Morairty SR.
    Sleep; 2016 Feb 01; 39(2):379-91. PubMed ID: 26446107
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG140 knock-in mouse model of Huntington's disease.
    Stefanko DP, Shah VD, Yamasaki WK, Petzinger GM, Jakowec MW.
    Neurobiol Dis; 2017 Sep 01; 105():15-32. PubMed ID: 28502806
    [Abstract] [Full Text] [Related]

  • 28. Diagnostic criteria for Huntington's disease based on natural history.
    Reilmann R, Leavitt BR, Ross CA.
    Mov Disord; 2014 Sep 15; 29(11):1335-41. PubMed ID: 25164527
    [Abstract] [Full Text] [Related]

  • 29. Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease.
    Kim JI, Long JD, Mills JA, McCusker E, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group.
    Neuropsychology; 2015 Nov 15; 29(6):949-60. PubMed ID: 26011117
    [Abstract] [Full Text] [Related]

  • 30. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Ribaï P, Nguyen K, Hahn-Barma V, Gourfinkel-An I, Vidailhet M, Legout A, Dodé C, Brice A, Dürr A.
    Arch Neurol; 2007 Jun 15; 64(6):813-9. PubMed ID: 17562929
    [Abstract] [Full Text] [Related]

  • 31. Exercise effects in Huntington disease.
    Frese S, Petersen JA, Ligon-Auer M, Mueller SM, Mihaylova V, Gehrig SM, Kana V, Rushing EJ, Unterburger E, Kägi G, Burgunder JM, Toigo M, Jung HH.
    J Neurol; 2017 Jan 15; 264(1):32-39. PubMed ID: 27747393
    [Abstract] [Full Text] [Related]

  • 32. Assessment of simple movements reflects impairment in Huntington's disease.
    Saft C, Andrich J, Meisel NM, Przuntek H, Müller T.
    Mov Disord; 2006 Aug 15; 21(8):1208-12. PubMed ID: 16700032
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's Disease.
    Tedroff J, Waters S, Barker RA, Roos R, Squitieri F, EHDN Registry Study Group.
    J Huntingtons Dis; 2015 Aug 15; 4(2):131-40. PubMed ID: 26397894
    [Abstract] [Full Text] [Related]

  • 35. Preparing for preventive clinical trials: the Predict-HD study.
    Paulsen JS, Hayden M, Stout JC, Langbehn DR, Aylward E, Ross CA, Guttman M, Nance M, Kieburtz K, Oakes D, Shoulson I, Kayson E, Johnson S, Penziner E, Predict-HD Investigators of the Huntington Study Group.
    Arch Neurol; 2006 Jun 15; 63(6):883-90. PubMed ID: 16769871
    [Abstract] [Full Text] [Related]

  • 36. Sample enrichment for clinical trials to show delay of onset in huntington disease.
    Paulsen JS, Lourens S, Kieburtz K, Zhang Y.
    Mov Disord; 2019 Feb 15; 34(2):274-280. PubMed ID: 30644132
    [Abstract] [Full Text] [Related]

  • 37. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS, Barret O, Jennings DL, Friedman JH, Tamagnan GD, Thomae D, Alagille D, Morley TJ, Papin C, Papapetropoulos S, Waterhouse RN, Seibyl JP, Marek KL.
    JAMA Neurol; 2014 Dec 15; 71(12):1520-8. PubMed ID: 25322077
    [Abstract] [Full Text] [Related]

  • 38. The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.
    Tippett LJ, Waldvogel HJ, Snell RG, Vonsattel JP, Young AB, Faull RLM.
    Adv Neurobiol; 2017 Dec 15; 15():129-161. PubMed ID: 28674980
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.